Literature DB >> 7569495

Robust Bayesian methods for monitoring clinical trials.

J B Greenhouse1, L Wasserman.   

Abstract

Bayesian methods for the analysis of clinical trials data have received increasing attention recently as they offer an approach for dealing with difficult problems that arise in practice. A major criticism of the Bayesian approach, however, has focused on the need to specify a single, often subjective, prior distribution for the parameters of interest. In an attempt to address this criticism, we describe methods for assessing the robustness of the posterior distribution to the specification of the prior. The robust Bayesian approach to data analysis replaces the prior distribution with a class of prior distributions and investigates how the inferences might change as the prior varies over this class. The purpose of this paper is to illustrate the application of robust Bayesian methods to the analysis of clinical trials data. Using two examples of clinical trials taken from the literature, we illustrate how to use these methods to help a data monitoring committee decide whether or not to stop a trial early.

Mesh:

Substances:

Year:  1995        PMID: 7569495     DOI: 10.1002/sim.4780141210

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  3 in total

1.  Determining the effective sample size of a parametric prior.

Authors:  Satoshi Morita; Peter F Thall; Peter Müller
Journal:  Biometrics       Date:  2007-08-30       Impact factor: 2.571

2.  Assessing placebo response using Bayesian hierarchical survival models.

Authors:  D K Stangl; J B Greenhouse
Journal:  Lifetime Data Anal       Date:  1998       Impact factor: 1.588

Review 3.  Prior Elicitation for Use in Clinical Trial Design and Analysis: A Literature Review.

Authors:  Danila Azzolina; Paola Berchialla; Dario Gregori; Ileana Baldi
Journal:  Int J Environ Res Public Health       Date:  2021-02-13       Impact factor: 3.390

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.